List of insiders holdings for Sio Gene Therapies Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | QVT Associates GP LLC QVT Offshore Ltd. 10% Owner |
2018-12-20 06:15:58 | 0 99,285,714 |
99,285,714 | Form 4 |
| 2 | QVT Associates GP LLC QVT Fund V LP 10% Owner |
2018-06-07 08:38:07 | 0 89,285,714 |
89,285,714 | Form 4 |
| 3 | Roivant Sciences Ltd. 10% Owner |
2020-02-27 21:59:49 | 18,577,380 0 |
18,577,380 | Form 13D |
| 4 | Hung David Principal Executive Officer |
2018-01-03 08:48:21 | 2,000,000 0 |
2,000,000 | Form 4 |
| 5 | Weinhoff Gregory M Principal Financial Officer |
2018-03-16 18:33:50 | 1,150,000 0 |
1,150,000 | Form 4 |
| 6 | Bazley Mathew C. General Counsel |
2019-04-17 21:13:06 | 976,000 0 |
976,000 | Form 4 |
| 7 | Nassif David W. Interim CEO, CFO |
2022-02-10 17:05:27 | 546,500 0 |
546,500 | Form 4 |
| 8 | McCourt Marion Principal Operating Officer |
2017-04-11 17:56:19 | 465,000 0 |
465,000 | Form 4 |
| 9 | Altmeyer Mark Pres (ASG) & Chief Comm. Ofc. |
2018-03-16 18:32:02 | 440,000 0 |
440,000 | Form 4 |
| 10 | Ramaswamy Vivek Principal Executive Officer 10% Owner |
2016-05-03 13:59:00 | 357,000 0 |
357,000 | Form 4 |
| 11 | Mohr Stephen Frederick General Counsel |
2018-03-16 18:31:12 | 350,000 0 |
350,000 | Form 4 |
| 12 | Cheruvu Pavan Chief Executive Officer |
2021-12-09 18:31:14 | 278,242 0 |
278,242 | Form 4 |
| 13 | Bickerstaff George Director |
2019-04-17 21:20:34 | 255,000 0 |
255,000 | Form 4 |
| 14 | POTTER MYRTLE S Director |
2019-04-17 21:19:25 | 255,000 0 |
255,000 | Form 4 |
| 15 | JEFFS ROGER Director |
2019-04-17 21:11:45 | 255,000 0 |
255,000 | Form 4 |
| 16 | Corcoran Gavin Chief R&D Officer |
2021-04-19 16:52:55 | 244,300 0 |
244,300 | Form 4 |
| 17 | FRIEDHOFF LAWRENCE MD PHD Chief Development Officer |
2017-05-02 20:57:09 | 200,000 0 |
200,000 | Form 4 |
| 18 | Meswani Parag V Chief Commercial Officer |
2022-02-10 17:07:32 | 153,700 0 |
153,700 | Form 4 |
| 19 | Roemer Alan S. Principal Fin & Acct Officer |
2015-06-10 18:32:32 | 100,000 0 |
100,000 | Form 3 |
| 20 | Lombardo Ilise Chief Medical Officer |
2018-08-17 17:26:42 | 100,000 0 |
100,000 | Form 4 |
| 21 | VERNON W ANTHONY Director |
2017-05-16 17:09:35 | 70,000 0 |
70,000 | Form 4 |
| 22 | FALBERG KATHRYN E Director |
2017-05-16 17:03:45 | 70,000 0 |
70,000 | Form 4 |
| 23 | Cvijic Christine Mikail Chief Admin Officer and GC |
2016-05-03 13:52:39 | 50,000 0 |
50,000 | Form 4 |
| 24 | Vuori Kristiina MD Director |
2021-04-19 16:59:14 | 42,000 0 |
42,000 | Form 4 |
| 25 | Torti Frank Director |
2021-04-19 16:57:48 | 42,000 0 |
42,000 | Form 4 |
| 26 | Sundaram Senthil Vel Director |
2021-04-19 16:56:48 | 42,000 0 |
42,000 | Form 4 |
| 27 | Pande Atul Director |
2021-04-19 16:55:29 | 42,000 0 |
42,000 | Form 4 |
| 28 | Modig Berndt Director |
2021-04-19 16:54:40 | 42,000 0 |
42,000 | Form 4 |
| 29 | OLANOFF LAWRENCE S Director |
2017-05-02 21:07:20 | 27,000 0 |
27,000 | Form 4 |
| 30 | Pisano Gary P. Director |
2017-05-02 21:05:56 | 27,000 0 |
27,000 | Form 4 |
| 31 | Romeo Marianne L. Head,Global Trans & Risk Mgmt |
2016-05-03 12:30:41 | 20,000 0 |
20,000 | Form 4 |
| 32 | Adasczik Michael Principal Accounting Officer |
2017-05-02 20:58:16 | 12,500 0 |
12,500 | Form 4 |
| 33 | Lo Andrew Former 10% Owner |
2019-07-16 18:00:18 | 0 0 |
0 | Form 13D |
| 34 | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Sundheim Daniel S. 10% Owner |
2019-07-15 09:22:44 | 0 0 |
0 | Form 13D |
| 35 | Venker Eric Director |
2020-02-19 17:35:20 | 0 0 |
0 | Form 3 |
| 36 | Machado Patrick Former 10% Owner |
2019-07-16 17:31:02 | 0 0 |
0 | Form 13D |
| 37 | Dexxon Holdings Ltd. Dexcel Pharma Technologies Ltd. Oren Dan See remarks |
2019-07-12 16:52:12 | 0 0 |
0 | Form 4 |
| 38 | VIKING GLOBAL PERFORMANCE LLC Viking Global Equities LP Viking Global Equities II LP VGE III Portfolio Ltd. Viking Global Equities Master Ltd. Viking Long Fund GP LLC Viking Long Fund Master Ltd. HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon Former 10% Owner |
2019-07-12 20:37:00 | 0 0 |
0 | Form 4 |
| 39 | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon Former 10% Owner |
2019-07-15 09:22:44 | 0 0 |
0 | Form 13D |
| 40 | QVT Associates GP LLC QVT Financial Investment Cayman Ltd. 10% Owner |
2019-07-12 16:32:48 | 0 0 |
0 | Form 4 |
| 41 | SVF Investments (UK) Ltd SoftBank Vision Fund L.P. SVF GP (Jersey) Ltd SVF Holdings (UK) LLP Former 10% Owner |
2019-07-12 19:49:35 | 0 0 |
0 | Form 4 |
| 42 | Oren Ilan Director |
2018-06-14 18:05:29 | 0 0 |
0 | Form 3 |